S.S.Healthcare

Ultravist 300mg I/ml Injection is known as a contrast agent. It is injected into the body before an X-ray test or CT scan to enhance the visibility of internal body structures like blood vessels and non-bony structures.

Ultravist 300mg I/ml Injection is administered by a healthcare professional in a hospital and clinical setting. This medicine should not be self-administered.

The most common side effects of this medicine include headache, nausea, injection site reactions, vasodilatation, vomiting, back pain, frequent urge to urinate, chest pain, taste change, and abnormal vision. If you experience any of this side effect and it bothers you, let your doctor know.

Ultravist 300mg I/ml Injection is known as a contrast agent. It is injected into the body before an X-ray test or CT scan to enhance the visibility of internal body structures like blood vessels and non-bony structures.

Ultravist 300mg I/ml Injection is administered by a healthcare professional in a hospital and clinical setting. This medicine should not be self-administered.

The most common side effects of this medicine include headache, nausea, injection site reactions, vasodilatation, vomiting, back pain, frequent urge to urinate, chest pain, taste change, and abnormal vision. If you experience any of this side effect and it bothers you, let your doctor know.

Ultravist 370mg I/ml Injection is known as a contrast agent. It is injected into the body before an X-ray test or CT scan to enhance the visibility of internal body structures like blood vessels and non-bony structures.

Ultravist 370mg I/ml Injection is administered by a healthcare professional in a hospital and clinical setting. This medicine should not be self-administered.

The most common side effects of this medicine include headache, nausea, injection site reactions, vasodilatation, vomiting, back pain, frequent urge to urinate, chest pain, taste change, and abnormal vision. If you experience any of this side effect and it bothers you, let your doctor know.

1 ml of solution for injection contains 604.72 mg gadobutrol (equivalent to 1.0 mmol gadobutrol containing 157.25 mg gadolinium).

1 vial with 2 ml contains 1209.44 mg gadobutrol,

1 vial with 7.5 ml contains 4535.4 mg gadobutrol,

1 vial with 15 ml contains 9070.8 mg gadobutrol,

1 vial with 30 ml contains 18141.6 mg gadobutrol.

1 bottle with 65 ml contains 39306.8 mg gadobutrol.

Excipient with known effect: 1 ml contains 0.00056 mmol (equivalent to 0.013 mg) of sodium (see section 4.4).

For the full list of excipients, see section 6.1.

Gadobutrol 604.72 mg/mL (1.0 mmol/mL) GADOVIST 1.0 is available as a 1.0 mmol/mL solution and each mL of GADOVIST 1.0 contains 604.72 mg gadobutrol. GADOVIST 1.0 M is a solution containing 604.72 mg/mL gadobutrol. Excipient with known effect: Each mL contains 0.00056 mmol (equivalent to 0.013 mg) of sodium. Based on the average amount given to a 70 kg person, this medicinal product contains less than 1 mmol sodium (23 mg) per dose (see section 4.4). For the full list of excipients,